Cargando…
Clinical Practice Guidelines for Achondroplasia*
Achondroplasia (ACH) is a skeletal dysplasia that presents with limb shortening, short stature, and characteristic facial configuration. ACH is caused by mutations of the FGFR3 gene, leading to constantly activated FGFR3 and activation of its downstream intracellular signaling pathway. This results...
Autores principales: | Kubota, Takuo, Adachi, Masanori, Kitaoka, Taichi, Hasegawa, Kosei, Ohata, Yasuhisa, Fujiwara, Makoto, Michigami, Toshimi, Mochizuki, Hiroshi, Ozono, Keiichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society for Pediatric Endocrinology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958518/ https://www.ncbi.nlm.nih.gov/pubmed/32029970 http://dx.doi.org/10.1297/cpe.29.25 |
Ejemplares similares
-
Clinical Practice Guidelines for Hypophosphatasia*
por: Michigami, Toshimi, et al.
Publicado: (2020) -
An overgrowth disorder associated with excessive production of cGMP due to a gain-of-function mutation of the natriuretic peptide receptor 2 (NPR2) gene
por: Miura, Kohji, et al.
Publicado: (2013) -
Inconvenience and adaptation in Japanese adult achondroplasia and
hypochondroplasia: A cross-sectional study
por: Ajimi, Akiko, et al.
Publicado: (2021) -
An Overgrowth Disorder Associated with Excessive Production of cGMP Due to a Gain-of-Function Mutation of the Natriuretic Peptide Receptor 2 Gene
por: Miura, Kohji, et al.
Publicado: (2012) -
Endocrinological and phenotype evaluation in a
patient with acrodysostosis
por: Ueyama, Kaoru, et al.
Publicado: (2017)